4.6 • 2000+ reviews

Compounded GLP-1 Injection

  • Same price, every dose

  • No hidden fees

  • Fast, free shipping

  • No insurance required

Compounded GLP-1
Compounded GLP-1 + GIP
$129 $179

1 month supply

$50 off first order - auto-applied at checkout

Get started
Important safety information

Important Safety Information

Refer to the following important safety details for information on intended use, potential side effects and risks, considerations for specific groups, and possible drug interactions linked to the prescription treatments mentioned.

Amble encourages users to promptly report any side effects or adverse reactions to a licensed healthcare provider and the pharmacy that dispensed the medication. To report suspected reactions, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

For emergencies, call 911 or go to your nearest emergency department.

Advertisements by Amble

All advertisements from joinamble.com are paid for by Amble Health, Inc. and are intended to market Amble’s services. Some advertisements may feature paid actors or dramatizations. When real Amble customers or endorsements are included, this will be clearly disclosed. Individual results may vary, and specific outcomes are not guaranteed.

Amble’s Role

Amble connects users with licensed healthcare providers for evaluations regarding the suitability of the treatments advertised. It may also assist with prescription coordination through an external pharmacy network.

Amble acts as a managed services provider and does not offer medical advice, fill prescriptions, or function as a licensed healthcare facility or pharmacy. Instead, it provides technology and administrative support to enable medical consultations and prescription logistics. For further details, see Amble’s Terms of Service.

Promotional Offers on joinamble.com

Occasionally, joinamble.com may present promotional pricing or special introductory offers. These promotions are valid for 24 hours after they are removed from the website.

The claim “same price at every dose” is subject to the following:

• Pricing may change at any time due to supply or market conditions at the discretion of joinamble.com.

• Any “same price at every dose” promotion expires within 24 hours of any price updates.

• Introductory or promotional pricing, including “first month” offers, are not governed by the “same price per dose” policy and only apply to full-price products as listed on the website.

Prescriptions and Medications

Prescription drugs require evaluation and approval by a qualified healthcare provider, and issuance is solely at the provider’s discretion. Access to treatment plans and medications is not assured.

Prescriptions issued through Amble may be filled by licensed pharmacies within its affiliated network.

All prescription medications involve potential risks. Please review all associated safety details and consult your provider for personalized advice.

Compounded Drug Formulations

In certain situations, healthcare providers may prescribe compounded medications, which are custom-prepared by licensed compounding pharmacies based in the U.S. These medications are not FDA-approved for safety or effectiveness but may be used when alternatives are not available or appropriate.

Amble helps facilitate both FDA-approved and compounded medication fulfillment via its partner pharmacy network. These formulations are personalized to meet individual patient requirements and may differ from commercial products.

Trademark Notice

Mounjaro® and Zepbound® are registered trademarks owned by Eli Lilly and Company. Amble is not affiliated with or endorsed by the manufacturers of any brand-name medications. For further information, visit Eli Lilly’s official website.

Contact Information

For any questions about Amble’s services or advertising content, please reach out to: [email protected].

‍

Semaglutide

Important Safety Information Regarding Compounded Semaglutide Products

Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy, similar to FDA-approved commercially available products. Compounded products may still be legally prescribed, and your healthcare provider may issue you a prescription for compounded semaglutide based on your medical consultation.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:

  • 30 kg/m2 or greater (obesity) or
  • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

Speak with your healthcare provider to see if semaglutide may be right for you.

Semaglutide may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, semaglutide caused thyroid tumors, including thyroid cancer. It is not known if semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.

Who should not use semaglutide:

  • Do not use semaglutide if you or any family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use semaglutide if you have had a serious allergic reaction to semaglutide in the past.

Before starting semaglutide, tell your healthcare provider if you have any other medical conditions, including if you:

  • Have or have had problems with your pancreas or kidneys.
  • Have type 2 diabetes and a history of diabetic retinopathy.
  • Have or have had depression, suicidal thoughts, or mental health issues.
  • Are pregnant or plan to become pregnant. Semaglutide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to semaglutide during pregnancy. You should stop using semaglutide for at least 2 months before you plan to become pregnant.
  • Are breastfeeding or plan to breastfeed. It is not known if semaglutide passes into your breast milk.

Tell your healthcare provider about all the medicines you take. This includes prescription medications, over-the-counter medicines, vitamins, and herbal supplements. Semaglutide may affect the way some medicines work, and some medicines may affect the way semaglutide works.

Serious side effects can occur with semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dosage changes. Semaglutide may cause serious side effects, including:

  • Thyroid C-Cell Tumors. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, semaglutide caused thyroid tumors, including thyroid cancer. It is not known if semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.
  • Paralysis of the stomach (gastroparesis). The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting. Contact your healthcare provider if you experience any of these symptoms.
  • Inflammation of your pancreas (pancreatitis). Stop using semaglutide and contact your healthcare provider immediately if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting.
  • Gallbladder problems. Semaglutide may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Contact your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take semaglutide.
  • Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • Serious allergic reactions. Stop using semaglutide and seek medical attention if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • Change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision with semaglutide.
  • Increased heart rate. Semaglutide may increase your heart rate while you are at rest. Talk to your healthcare provider if you feel your heart racing or pounding.
  • Depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Contact your healthcare provider immediately if you have any mental changes that are new, worse, or worry you.

The most common side effects of semaglutide may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, and runny nose or sore throat.

If you are experiencing a medical emergency, call 911 or seek immediate medical attention.

You are encouraged to report negative side effects of prescription products:

Semaglutide administration. Semaglutide can be taken with or without food. The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. For detailed instructions on how to administer your dose, please speak with your healthcare provider. They will guide you on a treatment regimen and explain to self-administer the medication. You should not change your dosing regimen or stop taking semaglutide as prescribed without first discussing with your healthcare provider.

This information is not comprehensive. Please discuss with your healthcare provider any questions or concerns you have regarding semaglutide.

‍

Tirzepatide

Important Safety Information Regarding Compounded Tirzepatide Products

Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy, similar to FDA-approved commercially available products. Compounded products may still be legally prescribed, and your healthcare provider may issue you a prescription for compounded tirzepatide based on your medical consultation.

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:

  • 30 kg/m2 or greater (obesity) or
  • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease).

Speak with your healthcare provider to see if tirzepatide may be right for you.

Tirzepatide may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, tirzepatide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors. It is unknown whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans.

Who should not use tirzepatide:

  • Do not use tirzepatide if you or any family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use tirzepatide if you have had a serious allergic reaction to tirzepatide in the past.

Before starting tirzepatide, tell your healthcare provider if you have any other medical conditions, including if you:

  • Have or have had problems with your pancreas or kidneys.
  • Have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • Have a history of diabetic retinopathy.
  • Have or have had depression, suicidal thoughts, or mental health issues.
  • Are pregnant or plan to become pregnant. Tirzepatide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to tirzepatide during pregnancy. You should discuss with your healthcare provider whether and how you should stop using tirzepatide before you plan to become pregnant.
  • Are breastfeeding or plan to breastfeed. It is not known if tirzepatide passes into your breast milk.

Tell your healthcare provider about all the medicines you take. This includes prescription medications, over-the-counter medicines, vitamins, and herbal supplements. Tirzepatide may affect the way some medicines work, and some medicines may affect the way tirzepatide works. If you are taking medicines to treat diabetes, including insulin or sulfonylureas, please let your healthcare provider know as tirzepatide could increase your risk of low blood sugar.

Serious side effects can occur with tirzepatide**. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dosage changes. Tirzepatide** may cause serious side effects, including:

  • Thyroid C-Cell Tumors. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if tirzepatide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.
  • Paralysis of the stomach (gastroparesis). The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting. Contact your healthcare provider if you experience any of these symptoms. Tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is therefore not recommended in these patients.
  • Inflammation of your pancreas (pancreatitis). Stop using tirzepatide and contact your healthcare provider immediately if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting.
  • Gallbladder problems. Tirzepatide may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Contact your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take tirzepatide.
  • Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • Serious allergic reactions. Stop using tirzepatide and seek medical attention if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • Change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision with tirzepatide.
  • Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use tirzepatide with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.
  • Depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Contact your healthcare provider immediately if you have any mental changes that are new, worse, or worry you.

The most common side effects of tirzepatide include: nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of tirzepatide. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

If you are experiencing a medical emergency, call 911 or seek immediate medical attention.

You are encouraged to report negative side effects of prescription products:

Tirzepatide administration. The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. For detailed instructions on how to administer your dose, please speak with your healthcare provider. They will guide you on a treatment regimen and explain to self-administer the medication. You should not change your dosing regimen or stop taking tirzepatide as prescribed without first discussing with your healthcare provider.

This information is not comprehensive. Please discuss with your healthcare provider any questions or concerns you have regarding tirzepatide.

Prescription required. Medication provided only if deemed medically appropriate by a licensed provider.

Add NAD+ Injection
MOST POPULAR
$250
total instead of $528

Same price every dose - price locked at $250 no price increase

No thanks, continue
with GLP-1 + GIP only
$229
$329
$250 $528

1 month supply

Price locked at $250. No price increase.

Get started
Important safety information

Important Safety Information

Refer to the following important safety details for information on intended use, potential side effects and risks, considerations for specific groups, and possible drug interactions linked to the prescription treatments mentioned.

Amble encourages users to promptly report any side effects or adverse reactions to a licensed healthcare provider and the pharmacy that dispensed the medication. To report suspected reactions, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

For emergencies, call 911 or go to your nearest emergency department.

Advertisements by Amble

All advertisements from joinamble.com are paid for by Amble Health, Inc. and are intended to market Amble’s services. Some advertisements may feature paid actors or dramatizations. When real Amble customers or endorsements are included, this will be clearly disclosed. Individual results may vary, and specific outcomes are not guaranteed.

Amble’s Role

Amble connects users with licensed healthcare providers for evaluations regarding the suitability of the treatments advertised. It may also assist with prescription coordination through an external pharmacy network.

Amble acts as a managed services provider and does not offer medical advice, fill prescriptions, or function as a licensed healthcare facility or pharmacy. Instead, it provides technology and administrative support to enable medical consultations and prescription logistics. For further details, see Amble’s Terms of Service.

Promotional Offers on joinamble.com

Occasionally, joinamble.com may present promotional pricing or special introductory offers. These promotions are valid for 24 hours after they are removed from the website.

The claim “same price at every dose” is subject to the following:

• Pricing may change at any time due to supply or market conditions at the discretion of joinamble.com.

• Any “same price at every dose” promotion expires within 24 hours of any price updates.

• Introductory or promotional pricing, including “first month” offers, are not governed by the “same price per dose” policy and only apply to full-price products as listed on the website.

Prescriptions and Medications

Prescription drugs require evaluation and approval by a qualified healthcare provider, and issuance is solely at the provider’s discretion. Access to treatment plans and medications is not assured.

Prescriptions issued through Amble may be filled by licensed pharmacies within its affiliated network.

All prescription medications involve potential risks. Please review all associated safety details and consult your provider for personalized advice.

Compounded Drug Formulations

In certain situations, healthcare providers may prescribe compounded medications, which are custom-prepared by licensed compounding pharmacies based in the U.S. These medications are not FDA-approved for safety or effectiveness but may be used when alternatives are not available or appropriate.

Amble helps facilitate both FDA-approved and compounded medication fulfillment via its partner pharmacy network. These formulations are personalized to meet individual patient requirements and may differ from commercial products.

Trademark Notice

Mounjaro® and Zepbound® are registered trademarks owned by Eli Lilly and Company. Amble is not affiliated with or endorsed by the manufacturers of any brand-name medications. For further information, visit Eli Lilly’s official website.

Contact Information

For any questions about Amble’s services or advertising content, please reach out to: [email protected].

‍

Semaglutide

Important Safety Information Regarding Compounded Semaglutide Products

Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy, similar to FDA-approved commercially available products. Compounded products may still be legally prescribed, and your healthcare provider may issue you a prescription for compounded semaglutide based on your medical consultation.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:

  • 30 kg/m2 or greater (obesity) or
  • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

Speak with your healthcare provider to see if semaglutide may be right for you.

Semaglutide may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, semaglutide caused thyroid tumors, including thyroid cancer. It is not known if semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.

Who should not use semaglutide:

  • Do not use semaglutide if you or any family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use semaglutide if you have had a serious allergic reaction to semaglutide in the past.

Before starting semaglutide, tell your healthcare provider if you have any other medical conditions, including if you:

  • Have or have had problems with your pancreas or kidneys.
  • Have type 2 diabetes and a history of diabetic retinopathy.
  • Have or have had depression, suicidal thoughts, or mental health issues.
  • Are pregnant or plan to become pregnant. Semaglutide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to semaglutide during pregnancy. You should stop using semaglutide for at least 2 months before you plan to become pregnant.
  • Are breastfeeding or plan to breastfeed. It is not known if semaglutide passes into your breast milk.

Tell your healthcare provider about all the medicines you take. This includes prescription medications, over-the-counter medicines, vitamins, and herbal supplements. Semaglutide may affect the way some medicines work, and some medicines may affect the way semaglutide works.

Serious side effects can occur with semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dosage changes. Semaglutide may cause serious side effects, including:

  • Thyroid C-Cell Tumors. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, semaglutide caused thyroid tumors, including thyroid cancer. It is not known if semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.
  • Paralysis of the stomach (gastroparesis). The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting. Contact your healthcare provider if you experience any of these symptoms.
  • Inflammation of your pancreas (pancreatitis). Stop using semaglutide and contact your healthcare provider immediately if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting.
  • Gallbladder problems. Semaglutide may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Contact your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take semaglutide.
  • Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • Serious allergic reactions. Stop using semaglutide and seek medical attention if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • Change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision with semaglutide.
  • Increased heart rate. Semaglutide may increase your heart rate while you are at rest. Talk to your healthcare provider if you feel your heart racing or pounding.
  • Depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Contact your healthcare provider immediately if you have any mental changes that are new, worse, or worry you.

The most common side effects of semaglutide may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, and runny nose or sore throat.

If you are experiencing a medical emergency, call 911 or seek immediate medical attention.

You are encouraged to report negative side effects of prescription products:

Semaglutide administration. Semaglutide can be taken with or without food. The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. For detailed instructions on how to administer your dose, please speak with your healthcare provider. They will guide you on a treatment regimen and explain to self-administer the medication. You should not change your dosing regimen or stop taking semaglutide as prescribed without first discussing with your healthcare provider.

This information is not comprehensive. Please discuss with your healthcare provider any questions or concerns you have regarding semaglutide.

‍

Tirzepatide

Important Safety Information Regarding Compounded Tirzepatide Products

Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy, similar to FDA-approved commercially available products. Compounded products may still be legally prescribed, and your healthcare provider may issue you a prescription for compounded tirzepatide based on your medical consultation.

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of:

  • 30 kg/m2 or greater (obesity) or
  • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease).

Speak with your healthcare provider to see if tirzepatide may be right for you.

Tirzepatide may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, tirzepatide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors. It is unknown whether tirzepatide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans.

Who should not use tirzepatide:

  • Do not use tirzepatide if you or any family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use tirzepatide if you have had a serious allergic reaction to tirzepatide in the past.

Before starting tirzepatide, tell your healthcare provider if you have any other medical conditions, including if you:

  • Have or have had problems with your pancreas or kidneys.
  • Have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • Have a history of diabetic retinopathy.
  • Have or have had depression, suicidal thoughts, or mental health issues.
  • Are pregnant or plan to become pregnant. Tirzepatide should not be used during pregnancy and there may be potential risks to an unborn baby from exposure to tirzepatide during pregnancy. You should discuss with your healthcare provider whether and how you should stop using tirzepatide before you plan to become pregnant.
  • Are breastfeeding or plan to breastfeed. It is not known if tirzepatide passes into your breast milk.

Tell your healthcare provider about all the medicines you take. This includes prescription medications, over-the-counter medicines, vitamins, and herbal supplements. Tirzepatide may affect the way some medicines work, and some medicines may affect the way tirzepatide works. If you are taking medicines to treat diabetes, including insulin or sulfonylureas, please let your healthcare provider know as tirzepatide could increase your risk of low blood sugar.

Serious side effects can occur with tirzepatide**. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dosage changes. Tirzepatide** may cause serious side effects, including:

  • Thyroid C-Cell Tumors. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if tirzepatide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.
  • Paralysis of the stomach (gastroparesis). The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting. Contact your healthcare provider if you experience any of these symptoms. Tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is therefore not recommended in these patients.
  • Inflammation of your pancreas (pancreatitis). Stop using tirzepatide and contact your healthcare provider immediately if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting.
  • Gallbladder problems. Tirzepatide may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Contact your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take tirzepatide.
  • Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
  • Serious allergic reactions. Stop using tirzepatide and seek medical attention if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • Change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision with tirzepatide.
  • Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use tirzepatide with medicines that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.
  • Depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Contact your healthcare provider immediately if you have any mental changes that are new, worse, or worry you.

The most common side effects of tirzepatide include: nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of tirzepatide. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

If you are experiencing a medical emergency, call 911 or seek immediate medical attention.

You are encouraged to report negative side effects of prescription products:

Tirzepatide administration. The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. For detailed instructions on how to administer your dose, please speak with your healthcare provider. They will guide you on a treatment regimen and explain to self-administer the medication. You should not change your dosing regimen or stop taking tirzepatide as prescribed without first discussing with your healthcare provider.

This information is not comprehensive. Please discuss with your healthcare provider any questions or concerns you have regarding tirzepatide.

Prescription required. Medication provided only if deemed medically appropriate by a licensed provider.

HSA & FSA eligible
Stylized vial for marketing purposes only; image does not reflect the actual label or size of prescription vial. Compounded products are not approved nor evaluated for safety, efficacy, or quality by the FDA.

What you get with Amble

- Multiple treatment plan options with dose adjustments if clinically appropriate
- Quick online assessment and licensed physician review
- Secure 24/7 messaging and scheduled check-ins with your physician
- If prescribed, medication ships directly to your door — no pharmacy trip required
- All plans include supplies, shipping, and ongoing clinical monitoring

How to take it

- Once-weekly subcutaneous injection, on the same day each week (unless instructed otherwise by your physician).
- Step-by-step dose-escalation schedule to support tolerance and minimize side effects

Potential side effects

Common side effects of GLP-1 injections may include nausea, diarrhea, and vomiting. To help your body adjust, eligible patients may add-on a fast-acting anti-nausea medication.

How it works

Free assessment, 100% online

Answer some questions about your health history, lifestyle, and goals via our online medical intake.

Step 1
Take the assessment
Step 1

Prescription

A licensed medical provider will review your information and determine if the medication is right for you.

Step 2
Find out if I am eligible
Step 2

Free delivery

If prescribed, your medication is 
cold-shipped directly to your door at no extra cost.

Step 3
Get started
Step 3

Weight loss, backed by data

Based on reported results from 16,000+ Amble members

Drop a clothing size

88% of Amble members dropped a clothing size or more.
Get Started
Get started

34 lbs lost on average

Members lost an average of 34 lbs (≈ 15% of weight).
Get Started
Get started

Reduce your cravings

95% say their appetite is lower since starting Amble.
Get Started
Get started

Shrink your waist

Nearly 9 out of 10 saw their waist shrink by at least an inch. 2.5 inches lost on average.
Get Started
Get started

Individual results vary. Statistics shown reflect anonymized self-reported outcomes from 16,000+ U.S. Amble program members surveyed in May 2025; weight-loss numbers come from members’ own scale readings, waist-change figures are based on members’ tape-measure readings, and clothing-size changes reflect members’ stated apparel sizes. All results refer to participation in the full Amble weight loss program—which combines physician oversight, nutrition support, and, when clinically appropriate, FDA-approved GLP-1 medication or compounded GLP-1 medication dispensed by licensed pharmacies; no efficacy claims are made for any compounded drugs. Medication eligibility and outcomes depend on individual clinical evaluation. Common GLP-1 side effects include nausea and constipation; 0.3% of respondents described side effects as “unmanageable.” Consult a licensed medical professional to determine whether GLP-1 therapy within the Amble program is appropriate for you. The individual pictured is not an Amble member. Customers’ results have not been independently verified. Participants received compensation for participating in the survey.

4.6 • 2000+ reviews

Real people, real results

357 lbs
120 lbs
5’2”
Month 0
Month 24

“Amble changed my life. Their GLP-1 program made weight loss easier and safer, and I emerged not just lighter but more confident, energetic, and positive. The team’s consistent support made all the difference, and I’m truly grateful.”

Johnna, 30
342 lbs
121 lbs
5’4”
Month 0
Month 30

“After losing my sister to obesity, I’d nearly given up after years of failed diets. I never imagined I’d lose 221 pounds—or find peace in the process. Amble quieted the noise, gave me my health back, and showed me what freedom really feels like.”

Tara, 49
286 lbs
158 lbs
5’11”
Month 0
Month 11

“After dealing with obesity my entire life, I finally decided to make a change. I am down 128 pounds, and weigh less now than I did when I was 11 years old. Amble made it easy, affordable and accessible for me to get on a GLP-1. I’ve never had this much confidence before in my life!”

Alexis, 26
308 lbs
178 lbs
5’10”
Month 0
Month 7

“I never thought losing weight—let alone 130 pounds in 7 months—was possible. My gut issues are gone, and my bloodwork is perfect. Amble made it happen and truly changed my life.”

Robert, 50
235 lbs
135 lbs
5’7”
Month 0
Month 14

“I thought bariatric surgery would help me lose weight. It did, but then I regained 120 pounds. Enter Amble. I have achieved and am maintaining my goal weight and feel more confident than ever.”

Kimberly, 41
272 lbs
120 lbs
5’2”
Month 0
Month 17

“I finally know what it feels like to be ‘normal’, eat when I’m hungry & stop when I’m full. The food noise is gone. Metabolic syndrome, treated. I found hope and strength. If I can do it, so can YOU!”

Kelly, 45
300 lbs
170 lbs
5’9”
Month 0
Month 24

“At 23, my health was at serious risk, and I never thought I’d lose the weight. 
Then, I found Amble—everything changed. With their support and transparency, I’ve lost 130 lbs and feel healthier and happier than ever.”

Hope, 25
265 & 255 lbs
180 & 140 lbs
5’8” & 5’3”
Month 0
Month 9

“We didn’t want to wait for health issues to hit—we wanted to take control early. Together, we’ve lost over 200 pounds on a GLP-1. With Amble’s support, we built lasting habits and found a path that actually works. We’re not just healthier—we’re living fully, side by side.”

Summer, 24 & Tyler, 29
194 lbs
120 lbs
5’6”
Month 0
Month 10

“Amble makes staying on track simple. Everything is designed to be convenient and stress-free. As a mom with two kids at home, that’s exactly what I needed. I’ve felt seen, supported, and empowered in this chapter of my journey, and that kind of care makes all the difference.”

Shayla, 40
258 lbs
180 lbs
5’2”
Month 0
Month 28

“I spent years restarting every Monday, nothing stuck. Since starting at 258 lbs in March 2023, the food noise stopped, the weight came off, and I finally feel like myself again. Thanks to Amble, it was affordable and accessible. I've lost 78 pounds—and gained so much more.”

Nyk, 36
223 lbs
148 lbs
5’5””
Month 0
Month 13

“I thought GLP-1s would be like everything else—until they changed my life. I was in constant pain, on three blood pressure meds, and deeply unhappy. Now I’m off two meds, moving again, and doing things I never thought possible.”

Sammi, 42

All results refer to participation in the full Weight Loss by Amble program, a holistic program that combines personalized coaching, nutrition and lifestyle support, a reduced-calorie diet and exercise, and, when clinically appropriate, FDA-approved GLP-1 medication or compounded GLP-1 medication dispensed by licensed pharmacies pursuant to a prescription. Medication eligibility and outcomes depend on individual clinical evaluation. Compounded drugs provided through Amble have not been reviewed or approved by the U.S. Food and Drug Administration for safety or effectiveness. Before-and-after images are submitted by paid Amble affiliates. Results have not been independently verified and will vary from person to person. Available in all 50 states, restrictions apply. Discontinuing treatment may lead to weight regain.

Start your journey

Your questions, answered.

Is insurance required?

No. Amble offers transparent, flat-rate pricing without insurance and no hidden fees.  Medication, supplies, and shipping are all included.

Are video visits with a doctor required?

In most states, treatment can begin after an online health review. 



In New Mexico, Kansas, West Virginia, Louisiana, and Mississippi, a short video or audio visit is required.

How are compounded GLP‑1s sourced?

When prescribed, GLP-1 medications are dispensed by state-licensed, U.S. pharmacies. 503A pharmacies are licensed and regulated by state boards of pharmacy, while 503B outsourcing facilities are registered with FDA. Both types of compounding facilities operate under state and FDA regulations.

Can my dosage change during treatment?

Yes. Your provider may adjust your dose upon request based on your medical history and how you respond to treatment.

Can I use my FSA/HSA?

Yes—HSA and FSA cards are accepted for 3-month or longer plans.  We also provide itemized receipts in case you need to self-submit to your benefits provider.

When will I notice results?

Weight loss is gradual and varies from person to person.  Some members see changes in the first few weeks, while others notice progress over several months.

How long will I need to stay on the medication?

GLP-1 therapy is often intended for ongoing use. Stopping suddenly may allow previous triggers to return. Always consult your provider before making changes.

Who qualifies for compounded GLP‑1s through Amble?

A licensed provider will review your health history, goals, and current medication. If you meet medical criteria, your provider may prescribe a GLP-1 as part of your program.

Still have questions?
Send us a message